Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

International Collaboration for Hhealth Iinnovation, IHI Call 10

The 10th call from the Innovative Health Initiative Joint Undertaking, IHI, is a two-stage call. The call has three different topics: 1. Digital labeling for medical technology products and products for in vitro diagnostics, 2. Safeguarding innovation in secondary use of health data in the European Health Data Space, 3. Exposure, emissions and end of life management of per- and poly-fluoralkyl substances, PFAS in the healthcare sector.

This web page has been machine translated. If there are any uncertainties, please refer to the Swedish text.

The offer in brief

What can you apply for?

The partnership IHI’s call for proposals finances international cross-sectoral research and innovation projects that will contribute to new and long-term health solutions.

Who can apply?

The call for proposals targets larger international consortia with actors within health and life science: industry, universities, research institutes, public sector, civil society and small and medium-sized companies in and outside Europe.

How much can you apply for?

The requested amount depends on which target area is addressed, as well as how the applicants choose to shape their proposal and consortium. Total requested funding is in the order of 50 – 200 million Swedish krona.

Important dates

  • Important documents for proposal

    The partnership's tenth call for proposals is carried out in two stages, and has three themes: Documents describing these themes in more detail are attached below.
    Visit the IHI website for more information.

    Themes:

    1. Digital labelling, a source for comprehensive information on medical devices and in vitro diagnostic products.
    2. Enabling innovation with secondary use of health data in the European Health Data Area, EHDS.
    3. Exposure, release and final management of highly fluorinated substances, PFAS, in healthcare.

    DraftTopic 1_DigitalLabelling_v171024.pdf(1370785).pdf

    DraftTopic 1 DigitalLabelling_v171024 (pdf, 221 kB) DraftTopic 2_InnovationEHDS_171024 (pdf, 245 kB) DraftTopic 3_PFAS_v171024 (pdf, 542 kB)

    Any questions?

    If you have any questions, please don't hesitate to contact us.

    Dobril Petkov

    Ärendeansvarig

    +46 8 473 31 82

    Caroline Ekstrand

    Ärendemedlem

    +46 8 473 30 27

    Reference number 2024-03834